Thomas A. Pearson

Thomas A. Pearson's AcademicInfluence.com Rankings

Thomas A. Pearson

Medical

#2074

World Rank

#2472

Historical Rank

Public Health

#293

World Rank

#305

Historical Rank

Epidemiology

#350

World Rank

#369

Historical Rank

medical Degrees

Download Badge

Medical

Why Is Thomas A. Pearson Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Thomas A. Pearson's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. (2003) (5024)
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. (2006) (2183)
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. (2006) (2183)
AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. (2002) (1981)
Guidelines for the Primary Prevention of Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association (2011) (1472)
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. (2006) (1221)
The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. (2000) (1106)
How to interpret a genome-wide association study. (2008) (1004)
Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention. (2000) (887)
AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. (2001) (723)
AHA/ACC Scientific Statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. (2001) (628)
Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. (2007) (625)
High-monounsaturated fatty acid diets lower both plasma cholesterol and triacylglycerol concentrations. (1999) (608)
Dietary guidelines for healthy American adults. A statement for health professionals from the Nutrition Committee, American Heart Association. (1996) (554)
Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial (2018) (549)
Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association. (1998) (541)
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty‐person/ten‐country panel (2006) (478)
Stroke following coronary artery bypass grafting: a ten-year study. (1985) (435)
Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop. (1992) (434)
Principles for national and regional guidelines on cardiovascular disease prevention: a scientific statement from the World Heart and Stroke Forum. (2004) (386)
IMMUNOSUPPRESSION AND PLASMA-EXCHANGE IN THE TREATMENT OF GOODPASTURE'S SYNDROME (1976) (386)
Cholesterol and heart disease in older persons and women. Review of an NHLBI workshop. (1992) (386)
Guide to Preventive Cardiology for Women (1999) (362)
Cardiovascular Reactivity to the Cold Pressor Test as a Predictor of Hypertension (1989) (356)
The Importance of Population-Wide Sodium Reduction as a Means to Prevent Cardiovascular Disease and Stroke: A Call to Action From the American Heart Association (2011) (356)
Plasma Sphingomyelin Level as a Risk Factor for Coronary Artery Disease (2000) (326)
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: overview. (2004) (291)
Left Ventricular Hypertrophy as an Independent Predictor of Acute Cerebrovascular Events in Essential Hypertension (2001) (290)
Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations. (2005) (288)
Effects of reducing dietary saturated fatty acids on plasma lipids and lipoproteins in healthy subjects: the DELTA Study, protocol 1. (1998) (283)
American Heart Association guide for improving cardiovascular health at the community level: a statement for public health practitioners, healthcare providers, and health policy makers from the American Heart Association Expert Panel on Population and Prevention Science. (2003) (267)
A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial. (2005) (254)
Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial (2010) (238)
American Heart Association Guide for Improving Cardiovascular Health at the Community Level, 2013 Update: A Scientific Statement for Public Health Practitioners, Healthcare Providers, and Health Policy Makers (2013) (234)
New Tools for Coronary Risk Assessment: What Are Their Advantages and Limitations? (2002) (234)
Primary Prevention of Coronary Heart Disease: Guidance From Framingham A Statement for Healthcare Professionals From the AHA Task Force on Risk Reduction (1998) (232)
Guide to primary prevention of cardiovascular diseases. A statement for healthcare professionals from the Task Force on Risk Reduction. American Heart Association Science Advisory and Coordinating Committee. (1997) (223)
Dyslipidemia (2022) (209)
Demographics and cardiology, 1950-2050. (2000) (205)
Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: medical office assessment: Writing Group I. (2000) (200)
Normal triglyceride levels and coronary artery disease events: the Baltimore Coronary Observational Long-Term Study. (1998) (198)
Coffee consumption and the incidence of coronary heart disease. (1986) (195)
Comparison of the plasma levels of apolipoproteins B and A-1, and other risk factors in men and women with premature coronary artery disease. (1992) (186)
High Levels of Lp(a) With a Small Apo(a) Isoform Are Associated With Coronary Artery Disease in African American and White Men (2000) (172)
The role of fatty acid saturation on plasma lipids, lipoproteins, and apolipoproteins: I. Effects of whole food diets high in cocoa butter, olive oil, soybean oil, dairy butter, and milk chocolate on the plasma lipids of young men. (1993) (168)
Prevention Conference VI: Diabetes and Cardiovascular disease: Writing Group I: epidemiology. (2002) (166)
The association of low levels of HDL cholesterol and arteriographically defined coronary artery disease. (1979) (158)
When to start cholesterol-lowering therapy in patients with coronary heart disease. A statement for healthcare professionals from the American Heart Association Task Force on Risk Reduction. (1997) (156)
Plasma dehydroepiandrosterone and dehydroepiandrosterone sulfate in patients undergoing diagnostic coronary angiography. (1990) (153)
Comparison of monounsaturated fat with carbohydrates as a replacement for saturated fat in subjects with a high metabolic risk profile: studies in the fasting and postprandial states. (2007) (153)
Summary of the Scientific Conference on Dietary Fatty Acids and Cardiovascular Health: Conference Summary From the Nutrition Committee of the American Heart Association (2001) (151)
Alcohol and heart disease. (1996) (147)
Effects of moderate-fat (from monounsaturated fat) and low-fat weight-loss diets on the serum lipid profile in overweight and obese men and women. (2004) (145)
AHA/ACC scientific statement: consensus panel statement. Guide to preventive cardiology for women. American Heart Association/American College of Cardiology. (1999) (138)
ACCF/AHA 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for Primary Prevention of Cardiova (2009) (136)
Coronary arteriography in the study of the epidemiology of coronary artery disease. (1984) (125)
AHA/ACCF [corrected] 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association task force on performance measures (writing committee to develop performance measures for primary prevention (2009) (123)
Low fat and high monounsaturated fat diets decrease human low density lipoprotein oxidative susceptibility in vitro. (2001) (118)
Guide to Preventive Cardiology for Women.AHA/ACC Scientific Statement Consensus panel statement. (1999) (117)
27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 8. Organization of preventive cardiology service. (1996) (116)
Reducing saturated fat intake is associated with increased levels of LDL receptors on mononuclear cells in healthy men and women. (1997) (112)
Cardiovascular Disease in Developing Countries: Myths, Realities, and Opportunities (1999) (112)
The treatment gap in coronary artery disease and heart failure: community standards and the post-discharge patient. (1997) (108)
Dyslipidemias with desirable plasma total cholesterol levels and angiographically demonstrated coronary artery disease. (1990) (107)
Evaluation of random digit dialing as a method of control selection in case-control studies. (1992) (104)
ACC/AHA Special Report: Clinical Practice Guideline Implementation Strategies A Summary of Systematic Reviews by the NHLBI Implementation Science Work Group A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines (2017) (102)
A Model of the Causes of Management Turnover in Hotels (2001) (98)
Validity of physicians' self-reports of cardiovascular disease risk factors. (1993) (97)
Relationship between corticosteroid exposure and plasma lipid levels in heart transplant recipients. (1988) (96)
Alcohol and atherosclerosis. (1991) (94)
The effective treatment of postpericardiotomy syndrome after cardiac operations. A randomized placebo-controlled trial. (1990) (91)
The epidemiology of the postpericardiotomy syndrome: a common complication of cardiac surgery. (1988) (91)
Clonal characteristics of fibrous plaques and fatty streaks from human aortas. (1975) (91)
Antioxidant nutrient supplementation reduces the susceptibility of low density lipoprotein to oxidation in patients with coronary artery disease. (1996) (90)
ACC/AHA Special Report: Clinical Practice Guideline Implementation Strategies: A Summary of Systematic Reviews by the NHLBI Implementation Science Work Group: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2017) (90)
34th Bethesda Conference: Can atherosclerosis imaging techniques improve the detection of patients at risk for ischemic heart disease? (2003) (90)
Major stroke after coronary artery bypass surgery: changing magnitude of the problem. (1986) (87)
Community-wide cardiovascular disease prevention programs and health outcomes in a rural county, 1970-2010. (2015) (86)
Gout and risk for subsequent coronary heart disease. The Meharry-Hopkins Study. (1997) (85)
Translation of nutritional sciences into medical education: the Nutrition Academic Award Program. (2001) (84)
Explaining disparities in access to high-quality cardiac surgeons. (2004) (83)
Pooled analyses of effects on C-reactive protein and low density lipoprotein cholesterol in placebo-controlled trials of ezetimibe monotherapy or ezetimibe added to baseline statin therapy. (2009) (82)
AHA scientific statement: summary of the Scientific Conference on Dietary Fatty Acids and Cardiovascular Health. Conference summary from the Nutrition Committee of the American Heart Association. (2001) (81)
Optimal risk factor management in the patient after coronary revascularization. A statement for healthcare professionals from an American Heart Association Writing Group. (1994) (79)
An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial. (2007) (77)
Raising low levels of high-density lipoprotein cholesterol is an important target of therapy. (2000) (74)
Validation for MEDFICTS, a dietary assessment instrument for evaluating adherence to total and saturated fat recommendations of the National Cholesterol Education Program Step 1 and Step 2 diets. (2001) (74)
The effect of filtered-coffee consumption on plasma lipid levels. Results of a randomized clinical trial. (1992) (73)
The role of fatty acid saturation on plasma lipids, lipoproteins, and apolipoproteins: II. The plasma total and low-density lipoprotein cholesterol response of individual fatty acids. (1993) (70)
Prospective serial evaluation of myocardial perfusion and lipids during the first six months of pravastatin therapy: coronary artery disease regression single photon emission computed tomography monitoring trial. (2003) (70)
Ezetimibe added to ongoing statin therapy improves LDL-C goal attainment and lipid profile in patients with diabetes or metabolic syndrome (2006) (69)
Comparison of effects of ezetimibe/simvastatin versus simvastatin versus atorvastatin in reducing C-reactive protein and low-density lipoprotein cholesterol levels. (2007) (67)
Smoking behavior and attitudes toward smoking among hospital nurses. (1986) (65)
The human atherosclerotic plaque. (1977) (62)
Lowering dietary saturated fat and total fat reduces the oxidative susceptibility of LDL in healthy men and women. (2000) (61)
Independent Associations Between Metabolic Syndrome Severity and Future Coronary Heart Disease by Sex and Race. (2017) (60)
Osteoarthritis as a Determinant of an Adverse Coronary Heart Disease Risk Profile (1996) (60)
The American College of Cardiology Evaluation of Preventive Therapeutics (ACCEPT) study: attainment of goals for comprehensive risk reduction in patients with coronary disease in the US (1998) (60)
Independent associations between a metabolic syndrome severity score and future diabetes by sex and race: the Atherosclerosis Risk In Communities Study and Jackson Heart Study (2017) (60)
Coffee intake and coronary heart disease. (1994) (59)
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the population science discussion group. (2004) (59)
Youthful precursors of alcohol abuse in physicians. (1990) (58)
Incidence of coronary artery disease in siblings of patients with premature coronary artery disease: 10 years of follow-up. (2007) (57)
Elevated Blood Pressure, Race/Ethnicity, and C-Reactive Protein Levels in Children and Adolescents (2008) (56)
Clonal Markers in the Study of the Origin and Growth of Human Atherosclerotic Lesions (1978) (54)
Primer in Preventive Cardiology (1994) (53)
The epidemiologic basis for population-wide cholesterol reduction in the primary prevention of coronary artery disease. (2004) (51)
Effect of low-dose alcohol use versus abstention on apolipoproteins A-I and B. (1988) (51)
What to advise patients about drinking alcohol. The clinician's conundrum. (1994) (47)
Epidemiology of thrombotic-hemostatic factors and their associations with cardiovascular disease. (1997) (47)
Effects of a milk chocolate bar per day substituted for a high-carbohydrate snack in young men on an NCEP/AHA Step 1 Diet. (1994) (47)
Clinical predictors of oxidized low-density lipoprotein in patients with coronary artery disease. (1997) (45)
Lipid lowering in a multidisciplinary clinic compared with primary physician management. (1998) (45)
Importance of risk factors in the angiographic progression of coronary artery disease. (1986) (44)
The effects of age on outcome after coronary bypass surgery. (1987) (44)
The undertreatment of LDL-cholesterol: addressing the challenge. (2000) (44)
The epidemiology of idiopathic dilated cardiomyopathy in a biracial community. (1990) (43)
A documented episode of pulmonary vasoconstriction in systemic sclerosis. (1981) (42)
Apolipoprotein [a] genotype influences isoform dominance pattern differently in African Americans and Caucasians. (2002) (42)
Precursors of hypertension in black compared to white medical students. (1987) (42)
AHA / CDC Scientific Statement Markers of Inflammation and Cardiovascular Disease Application to Clinical and Public Health Practice : A Statement for Healthcare Professionals From the Centers for Disease Control and Prevention and the American Heart Association (2003) (41)
ApoE genotype does not predict lipid response to changes in dietary saturated fatty acids in a heterogeneous normolipidemic population. The DELTA Research Group. Dietary Effects on Lipoproteins and Thrombogenic Activity. (1997) (41)
Ethnic differences in achievement of cholesterol treatment goals (2006) (41)
Training medical students in community health: a novel required fourth-year clerkship at the University of Rochester. (2008) (41)
Thyroid Cancer Risk 40+ Years after Irradiation for an Enlarged Thymus: An Update of the Hempelmann Cohort (2010) (40)
A global view of atherothrombosis: baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. (2005) (40)
Cardiovascular Disease in African American and White Physicians: The Meharry Cohort and Meharry-Hopkins Cohort Studies (1997) (40)
Prevalence of hyperlipidemia in heart transplant recipients. (1987) (38)
The prediction of midlife coronary heart disease and hypertension in young adults: the Johns Hopkins multiple risk equations. (1990) (38)
Lipid-lowering therapy in low-risk patients. (1998) (38)
Education and income: double-edged swords in the epidemiologic transition of cardiovascular disease. (2003) (37)
The prevention of cardiovascular disease: have we really made progress? (2007) (37)
Carotid endarterectomy and carotid artery stenting utilization trends over time (2012) (37)
Public policy approaches to the prevention of heart disease and stroke. (2011) (36)
High levels of inflammatory biomarkers are associated with increased allele-specific apolipoprotein(a) levels in African-Americans. (2008) (36)
The association of risk factors with arteriographically defined coronary artery disease: what is the appropriate control group? (1987) (36)
MONOCLONAL CHARACTERISTICS OF ORGANISING ARTERIAL THROMBI: SIGNIFICANCE IN THE ORIGIN AND GROWTH OF HUMAN ATHEROSCLEROTIC PLAQUES (1979) (35)
Clonal characteristics in layers of human atherosclerotic plaques. A study of the selection hypothesis of monoclonality. (1978) (34)
Comprehensive endovascular therapy for femoropopliteal arterial atherosclerotic occlusive disease. (2005) (34)
Who is maintaining weight in a middle-aged population in Sweden? A longitudinal analysis over 10 years (2007) (34)
Protective effect of apolipoprotein E2 on coronary artery disease in African Americans is mediated through lipoprotein cholesterol Published, JLR Papers in Press, August 3, 2006. (2006) (33)
Adiponectin levels are associated with coronary artery disease across Caucasian and African-American ethnicity. (2007) (31)
Variation of lipids and lipoproteins in premenopausal women compared with men and postmenopausal women. DELTA (Dietary Effects on Lipoproteins and Thrombogenic Activity) Investigators. (2000) (31)
Effectiveness of ezetimibe added to ongoing statin therapy in modifying lipid profiles and low-density lipoprotein cholesterol goal attainment in patients of different races and ethnicities: a substudy of the Ezetimibe add-on to statin for effectiveness trial. (2006) (31)
Age as a Modulator of Inflammatory Cardiovascular Risk Factors (2011) (30)
Long-term effects of cigarette smoking and moderate alcohol consumption on coronary artery diameter. Mechanisms of coronary artery disease independent of atherosclerosis or thrombosis? (1986) (30)
Risk factors in siblings of people with premature coronary heart disease. (1988) (30)
Lateral automobile impacts and the risk of traumatic brain injury. (2004) (30)
Thrombolysis with recombinant tissue plasminogen activator in atherosclerotic thrombotic occlusion. (1985) (29)
LDL-cholesterol: a risk factor for coronary artery disease--from epidemiology to clinical trials. (1998) (29)
Metabolic syndrome components in african-americans and European-american patients and its relation to coronary artery disease. (2007) (29)
Association of lipoprotein-associated phospholipase A2 with coronary artery disease in African-Americans and Caucasians. (2010) (29)
Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial. (2005) (28)
Measurements and the knowledge revolution (1999) (28)
Integration of the Case-Based Series in Population-Oriented Prevention into a problem-based medical curriculum. (2003) (28)
Community-based prevention trials: Challenges and directions for public health practice, policy, and research (1997) (26)
Synergistic role of inflammation and insulin resistance as coronary artery disease risk factors in African Americans and Caucasians. (2009) (26)
Are Central Institutional Review Boards the Solution? The National Heart, Lung, and Blood Institute Working Group’s Report on Optimizing the IRB Process (2012) (25)
Seasonal variation in parameters related to coronary heart disease risk in young men. (1996) (25)
High obesity incidence in northern Sweden: How will Sweden look by 2009? (2006) (25)
Cardiovascular specialty societies and the emerging global burden of cardiovascular disease: a call to action. (1998) (25)
Screening family members at high risk for coronary disease. Why isn't it done? (2001) (25)
Usefulness of apolipoprotein B/apolipoprotein A-I ratio to predict coronary artery disease independent of the metabolic syndrome in African Americans. (2010) (24)
Comparison of the effects of diets rich in stearic acid versus myristic acid and lauric acid on platelet fatty acids and excretion of thromboxane A2 and PGI2 metabolites in healthy young men. (1993) (24)
AJC editor's consensus: rheumatoid arthritis and atherosclerotic cardiovascular disease. (2010) (24)
Breast Cancer Risk 55+ Years After Irradiation for an Enlarged Thymus and Its Implications for Early Childhood Medical Irradiation Today (2010) (24)
Anabolic action of parathyroid hormone (PTH) does not compromise bone matrix mineral composition or maturation. (2016) (23)
Apo[a] size and PNR explain African American-Caucasian differences in allele-specific apo[a] levels for small but not large apo[a] Published, JLR Papers in Press, February 22, 2006. (2006) (23)
Lipid lowering. (1996) (23)
The rapid reduction in cardiac events with lipid-lowering therapy: mechanisms and implications. (1993) (22)
The clonal characteristics of human aortic intima. Comparison with fatty streaks and normal media. (1983) (22)
Clonal characteristics of experimentally induced "atherosclerotic" lesions in the hybrid hare. (1979) (22)
Issues of validation in quantitative coronary angiography (1988) (22)
Stearic acid and cardiovascular disease—answers and questions (1994) (22)
Bridging the treatment gap: improving compliance with lipid-modifying agents and therapeutic lifestyle changes. (2003) (21)
Idiopathic dilated cardiomyopathy and atopic disease: epidemiologic evidence for an association with asthma. (1989) (21)
Attainment of LDL-cholesterol goals in a national sample: results from the lipid treatment assessment project (L-TAP) (1998) (21)
Design and methodology challenges of environment-wide association studies: A systematic review. (2020) (20)
Assessing the added predictive ability of a metabolic syndrome severity score in predicting incident cardiovascular disease and type 2 diabetes: the Atherosclerosis Risk in Communities Study and Jackson Heart Study (2018) (20)
Smoking is a geriatric health issue. (1999) (19)
Invited commentary: should arteriographic case-control studies be used to identify causes of atherosclerotic coronary artery disease? (1991) (19)
EVIDENCE FOR TWO POPULATIONS OF FATTY STREAKS WITH DIFFERENT ROLES IN THE ATHEROGENIC PROCESS (1980) (19)
Characteristics of a hypothetical group of hospital controls for a case-control study. (1994) (19)
Clonal characteristics of cutaneous scars and implications for atherogenesis. (1981) (18)
Comparison of the dose-response relationships of 2 lipid-lowering agents: a Bayesian meta-analysis. (2003) (18)
Fewer deaths from cardiovascular disease than expected from the Systematic Coronary Risk Evaluation chart in a Swedish population (2009) (18)
ApoE genotype affects allele-specific apo[a] levels for large apo[a] sizes in African Americans: the Harlem-Basset Studys⃞ Published, JLR Papers in Press, December 15, 2006. (2007) (18)
Knowledge, Perception, and Behaviors of Relatives of People With Premature Heart Disease: A Systematic Literature Review (2011) (18)
Association of Lp-PLA(2) activity with allele-specific Lp(a) levels in a bi-ethnic population. (2010) (18)
Behavioral issues in the efficacy versus effectiveness of pharmacologic agents in the prevention of cardiovascular disease (1997) (17)
An external exposome-wide association study of hypertensive disorders of pregnancy. (2020) (17)
The Rorschach Interaction Scale as a potential predictor of cancer. (1986) (17)
Identifying Emerging Research Collaborations and Networks (2014) (17)
Cholesterol screening guidelines consensus, evidence, and the departure from common sense. (1997) (16)
Regional versus general anesthesia in high-risk surgical patients: the need for a clinical trial. (1989) (16)
Effect of irbesartan and enalapril in non-ST elevation acute coronary syndrome: results of the randomized, double-blind ARCHIPELAGO study. (2009) (16)
Lipids. Workshop IV. AHA Prevention Conference III. Behavior change and compliance: keys to improving cardiovascular health. (1993) (16)
Clonal mapping of the human aorta. Relationship of monoclonal characteristics, lesion thickness, and age in normal intima and atherosclerotic lesions. (1987) (16)
Atherosclerosis in the hypercholesterolemic hare. Comparison of coronary artery lesions induced by dietary cholesterol in the hare and the rabbit. (1987) (16)
An Epidemiologic Transition of Cardiovascular Disease Risk in Carriacou and Petite Martinique, Grenada: the Grenada Heart Project, 2005-2007 (2012) (15)
Cardiovascular diseases as a growing health problem in developing countries: the role of nutrition in the epidemiologic transition. (1996) (14)
The apolipoprotein(a) gene: linkage disequilibria at three loci differs in African Americans and Caucasians. (2008) (14)
Assessing Baseline and Temporal Changes in Cardiometabolic Risk Using Metabolic Syndrome Severity and Common Risk Scores (2018) (14)
Precision Health Analytics With Predictive Analytics and Implementation Research: JACC State-of-the-Art Review. (2020) (14)
Comparative lipid and lipoprotein responses to solid-food diets and defined liquid-formula diets. (1999) (13)
Community trials for cardiopulmonary health: Directions for public health practice, policy, and research (1997) (13)
Primary and secondary prevention of coronary artery disease: trials of lipid lowering with statins. (1998) (13)
Treatment of hypercholesterolemia in women: equality, effectiveness, and extrapolation of evidence. (1997) (13)
Identification and management of heterozygous familial hypercholesterolemia: summary and recommendations from an NHLBI workshop. (1993) (13)
Estimating cholesterol treatment rates among individuals with multiple risk factors and without coronary heart disease. (2005) (13)
Comparison of C-reactive protein and metabolic syndrome as cardiovascular risk factors in African-Americans and European-Americans. (2009) (12)
Task Force 4: The relationship between cardiovascular specialists and generalists. (1994) (12)
patient-oriented and epidemiological research ApoE and ApoC-I polymorphisms: association of genotype with cardiovascular disease phenotype in African Americans (2009) (12)
Cholesterol management in patients hospitalized for coronary heart disease. (1988) (12)
What to consider when conducting a cost-effectiveness analysis in a clinical setting. (1998) (12)
Aspirin in Primary Prevention: What Changed? A Critical Appraisal of Current Evidence. (2020) (12)
Do disease management programs for patients with coronary heart disease make a difference? Experiences of nine practices. (2002) (12)
Organizing services for cardiovascular prevention (2007) (11)
Risk factors for cardiovascular disease in U.S. medical students: the Preventive Cardiology Academic Award Collaborative Data Project. (1990) (11)
Differential associations of serum amyloid A and pentraxin-3 with allele-specific lipoprotein(a) levels in African Americans and Caucasians. (2011) (11)
Strategies for increasing house staff management of cholesterol with inpatients. (1990) (11)
AHA Science Advisory. Alcohol and heart disease. Nutrition Committee of the American Heart Association. (1997) (11)
The cardiovascular implications of omega-3 fatty acids (2006) (11)
Guidelines and their Implementation: A Discussion Document Focused on the Best Approaches to Drive Improvement (2004) (11)
What's so passive about passive smoking? Secondhand smoke as a cause of atherosclerotic disease. (1998) (10)
Task Force on Strategic Research Direction: Population/Outcomes/Epidemiology/Social Science Subgroup key science topics report. (2002) (10)
Heightened risk of cardiovascular disease in patients with rheumatoid arthritis, heightened risk of cardiovascular disease in patients with rheumatoid arthritis. Introduction. (2008) (10)
Population benefits of cholesterol reduction: epidemiology, economics, and ethics. (2000) (10)
Differing Effects of Parathyroid Hormone, Alendronate, and Odanacatib on Bone Formation and on the Mineralization Process in Intracortical and Endocortical Bone of Ovariectomized Rabbits (2018) (10)
Combination niacin and statin therapy in primary and secondary prevention of cardiovascular disease (2005) (10)
Clinical and angiographic similarities in twins with coronary artery disease. (1987) (10)
Influences on CHD incidence and case fatality: medical management of risk factors. (1989) (10)
Can single photon emission computed tomography myocardial perfusion imaging monitor the potential benefit of aggressive treatment of hyperlipidemia? (1997) (9)
Nutritional interventions in cardiovascular disease: New challenges and opportunities (2000) (9)
Screening of asymptomatic siblings of patients with premature coronary artery disease (1987) (9)
Attitudes toward prevention of cardiovascular diseases among first-year students at eight American medical schools, 1983-1985. (1988) (9)
Nutrient adequacy of diets of adults with hypercholesterolemia after a cholesterol-lowering intervention: long-term assessment. (2000) (8)
National Heart, Lung, and Blood Institute and Other Atherosclerotic Vascular Disease: 2006 Update: Endorsed by the AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary (2006) (8)
Atherosclerosis. Quantitative imaging, risk factors, prevalence, and change. Symposium proceedings. Orlando, Florida, March 1991. (1993) (8)
The quality of lifestyle and the quality of life. (2011) (7)
Post-Myocardial Infarction Cholesterol Management by Primary Physicians (1987) (7)
Screening for hypercholesterolemia. (1990) (7)
Global perspectives on cardiovascular disease. (1997) (7)
Understanding the Impact of Hyperlipidemia Treatment on Medical Expenditures for Cardiovascular Disease. (2017) (7)
Manolio How to Interpret a Genome-wide Association Study (2008) (7)
Hypercholesterolemia in patients undergoing coronary bypass surgery: are they aware, under treatment, and under control? (1988) (6)
Recent Advances in Preventive Cardiology and Lifestyle Medicine Public Policy Approaches to the Prevention of Heart Disease and Stroke (2011) (6)
Control and Prevention and the American Heart Association Health Practice: A Statement for Healthcare Professionals From the Centers for Disease Markers of Inflammation and Cardiovascular Disease : Application to Clinical and Public (2012) (6)
Effect of ACTH, α-MSH, and β-Lipotropin on Calcium and Phosphorus Metabolism in the Rabbit (1975) (6)
Guidelines for the detection and treatment of elevated serum cholesterol: which is the baby and which is the bathwater? (1991) (6)
Multiple risk factors for coronary artery disease: behavioral factors in preventive cardiology. (1987) (6)
Cardiovascular Health in the Developing World: Community Perceptions from Carriacou, Grenada. (2008) (5)
The rationale for renewed interest by physicians in nutrition (1999) (5)
Preventive cardiology and atherosclerotic disease (1994) (5)
The Quest for a Cholesterol-decreasing Diet: Should We Subtract, Substitute, or Supplement? (1993) (5)
Association Cardiovascular Disease and Stroke : A Call to Action From the American Heart The Importance of Population-Wide Sodium Reduction as a Means to Prevent (2011) (5)
Effects of diets containing high or low amounts of stearic acid on plasma lipoprotein fractions and fecal fatty acid excretion of men. (1996) (5)
Interdisciplinary Council on Quality of Care and Outcomes Research Blood Pressure Research, and Council on Peripheral Vascular Disease, and Cardiovascular Nursing, Council on Epidemiology and Prevention, Council for High on behalf of the American Heart Association Stroke Council, Council on (2011) (4)
Who will provide preventive services? The changing relationships between medical care systems and public health agencies in health care reform. (1995) (4)
Scandinavia's lessons to the world of public health (2000) (4)
Prevention of coronary heart disease in black adults. (1991) (4)
Diagnosis and case finding in familial hypercholesterolemia. (1993) (4)
American College of Physicians guidelines on cholesterol screening. (1996) (4)
Capacity for Research in Minority Health: The Need for Infrastructure Plus Will (2001) (4)
Racial variations in the choice of on-pump versus off-pump coronary artery bypass grafting (2007) (4)
Preventing heart attack and death in patients with coronary disease. Endorsed by the board of trustees of the American College of Cardiology. (1996) (4)
Section III—Trends in CHD in Selected Countries—Overview (1989) (4)
The imperative to raise low levels of high-density lipoprotein in cholesterol--a better clinical strategy in the prevention and treatment of coronary artery disease. Introduction. (2000) (3)
Therapeutic management of triglycerides: an international perspective. (1992) (3)
Workshop V--What is a risk factor and what is not--theoretical and practical implications. (1991) (3)
Aronow's "Should the NCEP III guidelines be changed in elderly and younger persons at high risk for cardiovascular events?" Commentary. (2005) (3)
Lipid lowering: the case for identifying and treating the high-risk patient. (1996) (3)
The Type and Amount of Dietary Fat Affect Plasma Factor VIIc, Fibrinogen, and PAI-1 in Healthy Individuals and Individuals at High Cardiovascular Disease Risk: 2 Randomized Controlled Trials. (2020) (3)
Assessment of Mortality and Smoking Rates Before and After Reduction in Community-wide Prevention Programs in Rural Maine (2019) (3)
Newly Diagnosed Type 2 Diabetics Have The Lowest Body Mass Index Change Among Rural Populations Of Sweden And The United States (2005) (2)
Monthly haemostatic factor variability in women and men (2014) (2)
A possible relationship between figure drawing data collected in medical school and later health status among physicians. (1986) (2)
Diet modification and food policy strategies: what works? (1997) (2)
Preventive cardiology: perspectives in physician education. (1990) (2)
MYOCARDIAL ISCHEMIA MAY BE MORE COMMON WITH REGIONAL THAN WITH GENERAL ANESTHESIA IN HIGH RISK PATIENTS (1986) (2)
Risk of coronary events 55 Years after Thymic irradiation in the Hempelmann cohort (2018) (2)
Undertreatment among high-risk dyslipidemic patients: results of a national survey of goal achievement for National Cholesterol Education Program Adult Treatment Panel III guidelines (2005) (2)
Nutritional interventions to reduce cardiovascular disease: Individual versus population perspectives (2001) (1)
Positioning technology to serve global heart health: the Fifth International Heart Health Conference (2004) (1)
Divergent approaches to the treatment of dyslipidemia with low levels of high-density lipoprotein cholesterol. (2000) (1)
Translation of evidence-based guidelines in preventive cardiology: the EUROACTION program (2009) (1)
Lowering LDL in patients with heart disease: how aggressive should you be? (2000) (1)
Disease Prevention Diseases in the United States : Findings of the National Conference on Cardiovascular Trends and Disparities in Coronary Heart Disease , Stroke , and Other Cardiovascular (2000) (1)
W12-P-051 An analysis of C-reactive protein and the efficacy of ezetimibe added to statin therapy (2005) (1)
Lipoprotein(a): Implications for clinical practice (2005) (1)
Coronary Artery Disease Incidence Over 10 Years in Siblings of Patients with Premature Coronary Artery Disease (2007) (1)
Pre-angiography plasma lipoprotein (a) levels in black patients and white patients. (1994) (1)
Serial quantitative single photon emission computed tomography monitors improved myocardial perfusion accompanying cholesterol reduction therapy (1998) (1)
Identification of those at risk for diabetes mellitus can comparative effectiveness research provide the answer? (2011) (1)
Abstract 042: Do Disparities In Cardiovascular Comorbidities Account For Excess Covid-19 Morbidity And Mortality In African Americans? (2021) (1)
Monthly hemostatic factor variability in women and men (2014) (1)
Abstract P100: Geographic Disparities in Hypertensive Disorders of Pregnancy: An Environment-Wide Association Study (2019) (1)
COFFEE AND PLASMA LIPID LEVELS. REPLY (1992) (1)
Blood cholesterol measurement in young adults. (1993) (1)
The Case for Identifying and Treating the High-Risk Patient (1996) (1)
Abstract P428: A Polyexposomic Risk Score for Hypertensive Disorders of Pregnancy Using External Exposome Data (2020) (1)
Hypercholesterolemia: nutritional and pharmacologic management. (1986) (0)
Coronary heart disease 55+ years after lower-dose thoracic irradiation: Preliminary results. (2010) (0)
Heart, Lung, and Blood Institute Other Atherosclerotic Vascular Disease: 2006 Update: Endorsed by the National AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and (2006) (0)
Over-the-counter statin medications: emerging opportunities for RDs. . (2000) (0)
Current focus in treating and managing coronary artery disease and heart failure (1997) (0)
Capacity for research in minority health: the need for infrastructure plus will. (2001) (0)
Community based cardiovascular risk reduction programs. (1988) (0)
Factor vilc activity and arteriographically defined coronary artery disease: Significant associations in african americans and women (1996) (0)
Epidemiologyof thrombotic-hemostaticfactorsand their associationswith cardiovasculardiseas&3 (2006) (0)
Organizing Services for Organizing Services for Cardiovascular Prevention Cardiovascular Prevention (2007) (0)
Risk factors for progression of coronary artery disease (1987) (0)
Physician recognition of CHD risk factors in high-risk patients. (1986) (0)
The use of 3-day food records in assessing dietary intake from hypercholesterolemic rural patients (1993) (0)
A Statement for Healthcare Professionals From the Markers of Inflammation and Cardiovascular Disease: Application to Clinical (2003) (0)
USING MACHINE LEARNING TO ASSESS RACIAL DISPARITIES IN COVID-19 MORBIDITY AND MORTALITY (2022) (0)
Why can't we do a better job? A systems approach to improving preventive cardiology services (2000) (0)
Effects of Parathyroid Hormone, Alendronate and Odanacatib on the mineralisation process in intracortical and endocortical Haversian bone of ovariectomized rabbits (2018) (0)
SHOULD PHYSICIANS CONSEL PATIENTS TO DRINK ALCOHOL ? AUTHOR'S REPLY (1995) (0)
Abstract P078: Gender And Racial Disparities In Aspirin Use For Primary Prevention: Temporal Trends From The National Health And Nutrition Examination Surveys, 2011-2018 (2021) (0)
EPIDEMIOLOGIC STUDIES Risk Factors in Siblings of People Wit reammature Coronary Heart Disease (2016) (0)
Estimating Cardiometabolic Risk Using Existing Scoring Systems (2018) (0)
Ischemic heart disease mortality declined sharply in Poland: an ecological study. (1998) (0)
SERIAL MYOCARDIAL PERFUSION IMAGING IN POTENTIAL RENAL TRANSPLANT RECIPIENT: FREQUENCY AND RISK FACTORS ASSOCIATED WITH NEW-ONSET PERFUSION ABNORMALITIES IN END STAGE RENAL DISEASE (2021) (0)
Decaffeinated coffee and serum LDL-cholesterol concentrations. (1992) (0)
Nutrient Metabolism Low Fat and High Monounsaturated Fat Diets Decrease Human Low Density Lipoprotein Oxidative Susceptibility In Vitro 1 , 2 (2001) (0)
Should Physicians Counsel Patients to Drink Alcohol?-Reply (1995) (0)
Abstract 1094: Inflammation Results In Increased Allele-specific Apo(a) Levels In African Americans: Potential Explanation For Inter-ethnic Difference? (2007) (0)
Abstract P235: Racial/ethnic and Geographic Disparities in Cardiovascular Health Among Pregnant Women in The United States (2020) (0)
Can Atherosclerotic Progression and Its Complications Be Prevented After Revascularization ? Overview of the Pathogenesis of Bypass Graft Closure and Post-PTCA Restenosis Saphenous Vein Bypass Graft Disease (2005) (0)
Complexity of association between apo(a) gene size & Lp(a) levels in Caucasians & African Americans — does size matter? (2000) (0)
B vitamins and restenosis after coronary angioplasty. (2002) (0)
dude the possibility that associations between CVD and hemo (2006) (0)
An international perspective on low-dose aspirin for the primary prevention of myocardial infarction. (2022) (0)
Cholesterol Lowering With Pravastatin Improves Resistance Artery Endothelial Function in Subjects With Normal Coronary Arteriograms (1998) (0)
Demographics and cardiology, 1950-2050. (2000) (0)
Effect of ACTH, alpha-MSH, and beta-Lipotropin on calcium and phosphorus metabolism in the rabbit. (1975) (0)
Abstract P341: Development of Predictive Models for Cardiovascular Health to Support Its Use in Real-world Data (2020) (0)
Lessons Learned from Lipid-Lowering Trials That Have Included Women (1997) (0)
Beyond LDL-cholesterol: can further reductions in CAD risk be achieved by considering triglycerides? (1998) (0)
C-REACTIVE PROTEIN (CRP) AND LDL-CHOLESTEROL RESPONSE TO EZETIMIBE MONOTHERAPY AND TO EZETIMIBE ADDED-ON TO BASELINE STATIN THERAPY (2008) (0)
Consensus Measures for Genome-wide Association Studies of Cardiovascular Outcomes (2009) (0)
Where do we go from here? (2008) (0)
The hybrid hare as a promising model of human atherosclerosis (1989) (0)
Anabolic parathyroid hormone (PTH) treatment does not alter periosteal bone mineral composition during primary and secondary mineralisation (2016) (0)
Lipids Workshop IV Participants (2005) (0)
Healthcare Providers, and Health Policy Makers Community Level, 2013 Update : A Scientific Statement for Public Health Practitioners, American Heart Association Guide for Improving Cardiovascular Health at the (2013) (0)
Abstract 17332: Are Current Electrocardiographic Criteria For Detecting LVH Relevant in African Americans? Evidence From the Jackson Heart Study (2011) (0)
Population and Prevention Science and Health Policy Makers From the American Heart Association Expert Panel on Community Level : A Statement for Public Health Practitioners, Healthcare Providers, American Heart Association Guide for Improving Cardiovascular Health at the (2012) (0)
Coffee consumption and the incidence of coronary heart disease. (1986) (0)
Intensity of testing and invasive procedures. (1996) (0)
Book Review Lipids and Vascular Disease: Current Issues Edited by D. John Betteridge. 262 pp., illustrated. London, Martin Dunitz, 2000. $120. 1-85317-627-3 (2001) (0)
JCL Roundtable: Gender differences in reduction of CVD in response to lipid-lowering drugs. (2015) (0)
Developing a Translational Research Workforce in the USA (2013) (0)
Abstract: P739 ASSOCIATION OF LP-PLA2 WITH CORONARY ARTERY DISEASE IN AFRICAN AMERICANS AND CAUCASIANS (2009) (0)
Issues and Opinions in Nutrition AHA Scientific Statement : Summary of the Scientific Conference on Dietary Fatty Acids and Cardiovascular Health 1 Conference Summary From the Nutrition Committee of the American Heart Association Conference Planning and Writing Committee : (2001) (0)
Interdisciplinary Council on Quali Blood Pressure Research, Council on Peripheral Vascular Disease, and Cardiovascular Nursing, Council on Epidemiology and Prevention, Council for High and on behalf of the American Heart Association Stroke Council, Council on (2010) (0)
Make Low-Cholesterol Diets Tasty (1994) (0)
Preliminary Studies on the Effect of Calcium on the Enzymatic Degradation of Human Calcitonin on the Dog (1975) (0)
Clinical and epidemiologic predictors of recurrent coronary artery disease. (1995) (0)
What's So Passive About Passive Smoking? (2016) (0)
Abstract P028: Do Increased Cardiovascular Comorbidities Explain Excess Covid-19 Morbidity And Mortality In African Americans? (2022) (0)
Moderate-risk patient with hypercholesterolemia: a pharmacy (P) model for decreasing LDL-cholesterol to reduce coronary heart disease risk (2006) (0)
Role of the Cardiologist and the Generalist i Cardiovascular Preventive Care (0)
Abstract 3900: Omega-3 and Omega-6 Fatty Acids and Risk of Recurrent Coronary Artery Events (2006) (0)
21614 Use of an Outcomes Continuum to Describe Disparities in CVOID-19: Data from the OneFlorida Research Consortium (2021) (0)
Abstract P260: Can Metabolic Syndrome Predict the Incidence of Silent Myocardial Infarction? An Analysis From the Atherosclerosis Risk in Communities (ARIC) Study (2018) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Thomas A. Pearson?

Thomas A. Pearson is affiliated with the following schools:

Thomas A. Pearson's Academic­Influence.com Rankings

Why Is Thomas A. Pearson Influential?

Thomas A. Pearson's Published Works

Published Works

What Schools Are Affiliated With Thomas A. Pearson?

Thomas A. Pearson's AcademicInfluence.com Rankings